Skin Tumors Induced by Sorafenib; Paradoxic RAS–RAF Pathway Activation and Oncogenic Mutations of <i>HRAS</i> , <i>TP53</i> , and <i>TGFBR1</i>J.-P. Arnault, Caroline Robert|Clinical Cancer Research|2011Cited by 120
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National CohortManon Girod, O. Dereure, E. Maubec et al.|JCO Precision Oncology|2022Cited by 14
Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanomaC. Mignard, P. Joly, A. Deschamps-Huvier et al.|Annals of Oncology|2018Cited by 13
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational studyS. Monestier, Stéphane Dalle, Laurent Mortier et al.|International Journal of Cancer|2021Cited by 9
Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic MelanomaO. Becquart, B. Guillot, Bastien Oriano et al.|Preprints.org|2021Cited by 2